BMO raises Gildan Activewear stock price target on Q1 beat By Investing.com

BMO Capital raised Gildan Activewear’s price target to $82 from $79 and reiterated an Outperform rating after the company beat first-quarter fiscal 2026 results and reaffirmed 2026 EPS growth guidance of 20% to 25%. Gildan reported adjusted EPS of $0.43 versus $0.3943 expected and revenue of $1.17 billion versus $1.15 billion consensus, with gains tied to HanesBrands integration and market share growth. Management still sees $80 million to $100 million of second-quarter inventory headwinds, but BMO expects stronger second-half earnings and free cash flow from synergies and plant consolidation.

Analysis

The market is starting to price Gildan less like a cyclical basics manufacturer and more like a post-integration cash compounder. The important second-order effect is that balance sheet and cost-synergy visibility compress the range of outcomes: when a low-growth apparel platform suddenly has a credible multi-quarter margin bridge, the stock can rerate faster than the underlying earnings growth. That makes the name more sensitive to execution milestones than to the macro tape over the next 1-2 quarters.

The key read-through for HBI is not just competitive pressure, but the possibility that the market begins to assign less strategic value to legacy scale and more to operational discipline. If GIL proves it can absorb integration friction while still taking share, HBI’s own restructuring path becomes a relative valuation issue for the whole category. Suppliers and channel partners may also become more willing to prioritize the cleaner operator, which can subtly reinforce share gains without requiring aggressive pricing.

The stock may still be underpricing the timing mismatch between headline enthusiasm and actual cash conversion. Near-term results can look noisy because inventory and integration drags defer free cash flow, so the best setup is likely in the 3-9 month window when investors start discounting second-half margin inflection rather than Q2 compression. The contrarian risk is that consensus is extrapolating synergy realization too cleanly; any slip in inventory normalization or a consumer demand wobble would hit a multiple that has already re-rated on certainty.

For now, this is a better relative-value story than an absolute chase. The strongest version is not that GIL is cheap on near-term earnings, but that its execution credibility is improving faster than the market’s willingness to pay for apparel growth. If that credibility holds through the next print, the stock can keep working even if the broader tape cools.

Key Decisions for Investors

• Long GIL on pullbacks into the next 2-4 weeks; target a 10-15% move over 3-6 months as the market starts discounting second-half synergy realization, with downside bounded if guidance is reiterated.
• Pair trade: long GIL / short HBI for 1-2 quarters to isolate execution divergence; the spread should benefit if investors keep rewarding clean integration and penalizing legacy restructuring drag.
• Sell cash-secured puts on GIL at strikes 8-12% below spot into elevated implied volatility; attractive if you want exposure while being paid for the near-term inventory overhang.
• If already long, trim only after the next catalyst passes and the market fully prices the FY26 synergy bridge; risk/reward deteriorates if the stock runs ahead of actual free cash flow conversion.